BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20442289)

  • 1. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo.
    Rubio R; García-Castro J; Gutiérrez-Aranda I; Paramio J; Santos M; Catalina P; Leone PE; Menendez P; Rodríguez R
    Cancer Res; 2010 May; 70(10):4185-94. PubMed ID: 20442289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
    Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
    Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
    Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
    Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
    Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
    Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells.
    Armesilla-Diaz A; Elvira G; Silva A
    Exp Cell Res; 2009 Dec; 315(20):3598-610. PubMed ID: 19686735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoma derived from cultured mesenchymal stem cells.
    Tolar J; Nauta AJ; Osborn MJ; Panoskaltsis Mortari A; McElmurry RT; Bell S; Xia L; Zhou N; Riddle M; Schroeder TM; Westendorf JJ; McIvor RS; Hogendoorn PC; Szuhai K; Oseth L; Hirsch B; Yant SR; Kay MA; Peister A; Prockop DJ; Fibbe WE; Blazar BR
    Stem Cells; 2007 Feb; 25(2):371-9. PubMed ID: 17038675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of RB and RB2/P130 genes in marrow stromal stem cells plasticity.
    Jori FP; Napolitano MA; Melone MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
    J Cell Physiol; 2004 Aug; 200(2):201-12. PubMed ID: 15174090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity.
    Milas M; Yu D; Lang A; Ge T; Feig B; El-Naggar AK; Pollock RE
    Cancer Gene Ther; 2000 Mar; 7(3):422-9. PubMed ID: 10766348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
    Bernardo ME; Zaffaroni N; Novara F; Cometa AM; Avanzini MA; Moretta A; Montagna D; Maccario R; Villa R; Daidone MG; Zuffardi O; Locatelli F
    Cancer Res; 2007 Oct; 67(19):9142-9. PubMed ID: 17909019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control.
    Pollock R; Lang A; Ge T; Sun D; Tan M; Yu D
    Clin Cancer Res; 1998 Aug; 4(8):1985-94. PubMed ID: 9717829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-like cells derived from human gastric cancer tissues.
    Cao H; Xu W; Qian H; Zhu W; Yan Y; Zhou H; Zhang X; Xu X; Li J; Chen Z; Xu X
    Cancer Lett; 2009 Feb; 274(1):61-71. PubMed ID: 18849111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro.
    Ren Z; Wang J; Zhu W; Guan Y; Zou C; Chen Z; Zhang YA
    Exp Cell Res; 2011 Dec; 317(20):2950-7. PubMed ID: 21963525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p53 and RB on in vitro growth of normal umbilical cord blood cells.
    Mahdi T; Alcalay D; Brizard A; Bois M; Millet C; Kitzis A; Tanzer J
    Exp Hematol; 1996 May; 24(6):702-12. PubMed ID: 8635526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein aggregate-containing neuron-like cells are differentiated from bone marrow mesenchymal stem cells from mice with neurofilament light subunit gene deficiency.
    Chao YX; He BP; Cao Q; Tay SS
    Neurosci Lett; 2007 May; 417(3):240-5. PubMed ID: 17395374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts.
    Zhou Z; Flesken-Nikitin A; Nikitin AY
    Cancer Res; 2007 Jun; 67(12):5683-90. PubMed ID: 17553900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.
    Song X; Zhou Y; Jia R; Xu X; Wang H; Hu J; Ge S; Fan X
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2626-35. PubMed ID: 20007825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.